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Abstract
The rate of hydrolysis of the aromatic rings of CP2TiX2 [X CI 1, 0200013 8 and
O2CCH2NH3CI 13], in aqueous solutions, 10%DMSO and 100% DMSO have been studied by H
NMR spectroscopy. Rapid hydrolysis of both the carboxylate and cyclopentadienyl ligands in
CP2TiX2 IX O2CCCI3, O2CCH2NH3CI occurs in DMSO to give biologically inactive species. The
rate of these reactions are concentration dependent as dilution of these samples with saline or
water to give the therapeutic conditions of 10%DMSO/90%H20 slows the hydrolysis chemistry. In
contrast, samples of Cp2TiX2 IX CI 1, O2CCH2NH3CI 13], dissolved in water give solutions
containing the presumed antitumour active species in which the halide or glycine ligands have
been hydrolysed but the Cp rings remain metal bound.
Introduction
The metallocene dihalides CP2MX2 (Cp =q5-C5H5; M Ti, Mo, Nb, V; X F, CI, Br, I, NCS,
N3, Y) are a relatively new class of small, hydrophobic organometallic anticancer agents that
exhibit antitumour properties against numerous cell lines including leukemia’s P388 and L1210,
colon 38 and Lewis lung carcinomas, B16 melanoma, solid and fluid Ehrlich ascites tumours and
several human colon and lung carcinomas transplanted into athymic mice [1,2,3]. Titanocene
dichloride (Cp2TiCI2) 1 has been the most widely studied metallocene and the drug entered phase
clinical trials in late 1991 [4]. Both biological and chemical studies support interaction with DNA
being involved in the mechanism of antitumour action. However, the active species responsible for
antitumour activity in vivo has not been identified.
Structure-activity studies, in which both the chloride ligands (Tables 1,2) and the Cp rings
have been modified, are consistent with the formation of a hydrolysed species ("CP2Ti2/’’) [5] as the
active species in vivo which is assumed to complex to DNA and interfere with normal cell
replication processes. Cp2TiCI2 1 undergoes rapid halide and cyclopentadienyl (Cp) hydrolysis to
form cyclopentadiene (CpH) and dicyclopentadiene, particularly at pH >4.0 [6]. However, these
hydrolysis products cause non-specific, local tumour inhibiting effects and do not exhibit the
systemic antitumour activity of Cp2TiCI2 [1,7]. The partially hydrolysed derivative CpTiCI3, which
lacks one of the Cp rings exhibits reduced activity [8], while substitution of the Cp rings, or bridging
of the two Cp rings resulted in significant loss of antitumour activity [1,9]. Thus, the unsubstituted
Cp rings are an important structural feature required to maintain antitumour activity.
In contrast, modification of the halide ligands is possible, provided the Ti-X bond remains
labile in aqueous solution. Thus derivatives CP2TiX2 (Table 1) retain antitumour activity, with
reduced or no actiVity in several cases (eg. X p-nitrophenoxy 10) attributed to pseudohalide
ligands that are too strongly bound to the titanium centre thus preventing dissociation in aqueous
systems [10]. Introduction of hydrophilic and charged X ligands (e.g. 7,8 and 9; Table 1) has
provided a mechanism whereby the aqueous solubility of complexes CP2TiX2 may be improved,
without significant perturbation of antitumour properties [11]. Very recently the synthesis and
biological activity of the highly water soluble amino acid derivatives 13 and 14 was reported
[12,13]. While in the solid state, complex 13 crystallises with the carboxylate groups coordinated to
the metal centre, in solution we have shown that the glycine ligands are only weakly coordinated to
the metal centre, and that, as in the case of Cp2TiCI2 (aq), the predominant species present in
aqueous solutions of 13 at pH 2-5 is "Cp2Ti2/’’ [14]. However, in contrast to all previously studied
titanocenes containing weakly coordinating halide or pseudo halide ligands, antitumour testing of
this derivative against Ehrlich ascites tumours did not show the expected 100% cure rates and
activity levels of only 50% were achieved (Table 1).
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In an effort to further define the key structural elements required in Cp2TiX2 to retain
antitumour activity, this paper reports a study of the hydrolysis chemistry [15] of titanocene
derivatives CP2TiXy (X CI 1, O2CCCI3 8 and O2CCH2NH3CI 13)in water and aqueous DMSO
mixtures. Particular attention was paid to the therapeutic conditions of 10% DMSO. The results
show that the effect of solvent is important, as in the case of the carboxylate ligands, Cp hydrolysis
is promoted in DMSO, leading to reduced amounts of the putative active species "CP2Ti
2/’’ in
solution. The results provide further molecular level information that is essential for the design of
related metallocene based anticancer drugs.
Y
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MATERIALS AND METHODS
General
Titanocene dichloride 1 was obtained from the Aldrich chemical company. The bisglycine
analogue 13 was prepared from titanocene dichloride 1 according to the literature procedure [12],
and purified and characterised as reported in [14]. Derivative 8 was prepared according to the
literature procedure [11] and was purified by recrystallisation in 87% yield; m.p. 173-174 C. H
NMR 200 MHz (CDCI3) 5 6.67 (s, 10H, Cp). IR spectrum (KBr disc, cm-1): 3114m; 1688s (C=O);
1444m; 1393m; 1333s; 1303s; 1020m; 961m; 869m; 839m; 732s; 680s. El MS m/z 437
(CpTi(OOCCCI3)2/, 4%); 341 and 339, (Cp2Ti(OOCCCI3)+, 63); 311, (CpTi(OOCCCI3)CI/, 52); 248,
(Cp2TiCI2+, 11); 213 (Cp2TiCI/, 30); 183, (CpTiCI2+, 100); 178, (Cp2Ti+, 3); 148, (CpTiCI+, 2). 1H
NMR spectra were recorded on a Bruker AC200 NMR spectrometer and were referenced to TSP
(0.00 ppm). DMSO refers to d6-DMSO.
Table 1 Effect of X ligand on biological activity of CP2TiX2 against fluid Ehrlich ascites
tumour; samples administered in 10%DMSO/saline
Compound
1
2
3
4
5
6
7
8
9
10
11
12
13
14
X ligand
CI
F
NCS
N3
SC6H4NH3CI
OCOCI3
’cis o2C.CH=CHCO2H
p-NO2CsH40
OC6F5
SC6F5
O2CCH2NH3Cl
’(L)- O2CCH(CH3)NH3CI
Optimum
Cure Rate
(%)
100
100
100
100
100
100
100
100
100
10
100
100
50
50
Optimum
dose range
(mg/kcj)
40-60
40
 o-8o
’60-100
80
50-70
60-i40
100-360
60-120
180-240
340-360
120-180
1’00-120
160
LD5o
(mg/kg)
100
60
135
145
135
95
175
440
170
260
480
260
>160
185
Ref.
1,19
1,19
1,19
1,19
1,19
1,2
2,11
1,11
1,11
1,10
1,10
12,13
12,13
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Hydrolysis Experiments
The general procedure involved dissolving 5- 15 mol of the complex in 500 1 D20 or
DMSO, or 10%DMSO/90%D20. For samples in 10%DMSO, the solid was first dissolved in DMSO,
and then diluted with D20 to the required volume. Sonication was carried out with an Elma
Transsonic Digital Bath. The solution pD was adjusted with DCI and NaOD. pD values were
measured using a Beckman F11 meter and a Mettler NMR tube pH probe and are related to the pH
meter reading by the formula pD pH(meter reading) + 0.4 [16]. Measured pD values are + 0.3
due to fluctuations in sample pH which occurred over 30 min. H NMR spectra were recorded at
time intervals with any developing precipitate ignored. The rate of Cp hydrolysis displacement was
estimated by integration of one of the two multiplets arising from free cyclopentadiene C5H5D (6.5
and 6.6 ppm at pD 6.2; 6.45 and 6.55 ppm in DMSO) versus the metal-bound C5H5 signals
(typically at ~6.65 ppm). In the case of 13 an estimate of the % hydrolysis was also made from
integration of the unbound glycine peak versus the metal bound-Cp signal as described in the
results section. Attempts to use TSP as an internal reference were unsatisfactory as coordination
of TSP to the metallocene was observed.
Table 2"
Compound
15
16
17
Effect of X ligand on biological activity of Cp2TiCIX against fluid Ehrlich ascites
tumour; samples administered in 10%DMSO/saline
X liga’nd
2,3,4-trichloropheno...xy
o-SC6H4CH3
o-SC6H4NH2
Optimum
Cure Rate
(%)
50
25
13
OptimLm
dose range
(mg/kg)
60-140
30-60
50-10’0
LD50
(mg/kg)
200
6O
100
Rf,
1,10
1,8
1,8
RESULTS
The rate of Cp hydrolysis of both 1 and 13 in water at different pD values has been
reported previously (see Table 3 [6,14]). Preliminary data for the hydrolysis of a number of
carboxylate complexes, including 8 have been reported. However, no details of the aqueous
solubility of 8, which is reported to be poor in an independent study [11], were given, and NMR
spectroscopy was not used to characterise the proposed complexes. There are no systematic
studies of the hydrolysis of 1, 8 or 13 in aqueous DMSO or neat DMSO.
The rate of Cp hydrolysis in 1, 8, 13 was measured using H NMR spectroscopy at regular
time intervals in D20, DMSO and 10%DMSO/D20 at 25 C, using similar methods to those
previously reported [14, 17]. Thus, an estimate of the Cp hydrolysis may be calculated from the
relative intensities of the new multiplets due to cyclopentadiene and dicyclopentadiene in solution.
In addition, hydrolysis is also apparent by formation of precipitates with time. As in previous
studies [ref], full characterisation of these precipitates has not been possible due to their poor
aqueous solubility, but formation of oligomers and bridged species containing Cp rings cannot be
ruled out. Hence the amount of precipitation was also used as an indicator of the amount of
hydrolysis occurring in solution. In the case of 1 and 8 the amount of precipitate could only be
estimated visually or by isolation and weighing the precipitate. However, in the case of 13, a more
accurate estimate was possible by integration of the glycine CH2 peak versus the cyclopentadienyl
protons. Fully dissolved complex 13 gives by integration a ratio of 10 4 Cp CH2. As
precipitation occurred the Cp signal decreased relative to the glycine peak consistent with
formation of degradation products derived from the Cp rings.
Hydrolysis in Water
The rate of Cp hydrolysis of complexes 1 and 13, including mixed experiments containing
equal amounts of both complexes, have been reported previously [14], and is summarised in Table
3. While the hydrolysis of both 1 and 13 is accompanied by formation of a minor amount of
insoluble precipitate at pD 2, all of the dissolved material contains the Cp rings bound to the
metal. Attempts to carry out similar experiments with 8 confirmed previous reports of poor
aqueous solubility the complex [11]. While the solubility was not quantified, the trichloroacetate
derivative 8 appeared to be less soluble than titanocene dichloride 1.
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(a) X CI
(i) 0.25 h
(b) X OOCCCI3 (c) X OOCCH2NH3CI (d) X Cl
+ 2 equiv, glycine
(ii) 3 h
Cp\
T
Cp
/
(iii) 24 h
’1
9.0 8.0 7.0 6.0 9.0 8.0 7.0 6.0 9.0 8.0 7.0
PPM PPM PPM PPM
Figure 1" Aromatic region of H NMR spectra (200 MHz, d6-DMSO, 25 oC) of Cp2TiX2 complexes
(a) 1, (b) 8 (c) 13 (d) 1 with 2 equivalents of glycine. Spectra recorded at (i) 0.25 h (ii) 3 h and
(iii) 24 h after complexes dissolved. Vertical axis is not to scale.
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Hydrolysis in 100% DMSO
Table 3 summarises the results obtained for the complexes CP2TiX2 (X CI 1, O2CCCI2 8,
glycine 13; 10 mol) in 100%DMSO. All complexes readily dissolved in this solvent with minimal
precipitation observed over a 24 h period. In each case, there are 2 competing hydrolysis
pathways that need to be considered (i) halide hydrolysis and (ii) ring (Cp) hydrolysis.
In the case of titanocene dichloride 1, negligible Cp hydrolysis occurred after 15 min and a
sharp singlet for the aromatic protons was observed (Figure la). After 24 h, by integration of the
newly formed multiplets from cyclopentadiene, it was estimated that approximately 30% of the Cp
rings in the complex had hydrolysed (Figure la). While it is difficult to monitor the rate of halide
hydrolysis in these experiments, a new minor downfield DMSO multiplet appeared after 3 h (2.95
ppm) and was assigned to DMSO coordinated to Ti through substitution of one (or both) chloride
ligands. This new multiplet increased in intensity at approximately the same rate as the new CpH
multiplets.
Table 3 Effect of solvent on rates of hydrolysis of aromatic rings in CP2TiX2.
Solvent 10%DMSO/D20
X Reaction % Cp
Time (h) a Hydrolysis
CI
1
O2CCCI3
8
glycine
13
ci
1
+ 2 equiv gly
0.25
3
24
6.25
3
24
0.25
3
24
6.25
3
25
DMSO
% Cp
Hydrolysis
[15]
<5
7
3O
>99
>99
>99
>99
>99
>99
40
80
>99
R’action’
Time (h)
0.25
3
24
0.25
3
24
0.25
3
24
<2
<2
<2
<2
<2
<2
<2
<2
20
a The time taken ,iter complete dis&olution was achieved; b Insoluble
D20 (pD ’~2-3)[14]
Reaction
Time (h)a
.b
.b
.b
24
% cp
hydrolysis
[15]
0
<2
In the case of complexes 8 and 13, rapid Cp hydrolysis occurred within 15 min (Figure
lb, lc), and after 24 h the singlets due to the metal bound Cp rings had completely disappeared
and only the characteristic cyclopentadiene (CpH) multiplets were observed. Solutions of 8 also
darkened after 24 h. As in the case of 1, a downfield DMSO multiplets appeared in these
experiments and were assigned tentatively to DMSO coordinated to titanium. This DMSO-Ti signal
increased in intensity with time and was the predominant species present after 24 h. A new
resonance also appeared in the spectra at around 8.4 ppm (Figure b, lc and d) and was
tentatively assigned as a binuclear degradation species similar to those reported previously, (eg.,
[Cp2Ti(X)O(X)TiCp2]2/ [18]). This resonance was sharp in solutions of complex 8 and broad in
solutions where glycine was present (Figure lc and ld).
In order to establish whether glycine, which appears to rapidly dissociate from the metal
when 13 is dissolved in DMSO, promotes the Cp hydrolysis reaction, glycine (HOOCCH2NH2, 2
mol equivalents) was added to a solution of Cp2TiCI2 1 and NMR spectra were recorded over 24 h.
After 15 min, approx 40% Cp hydrolysis had occurred, while after 3 h significant Cp hydrolysis
(80%) was observed (Figureld, Table 3). Thus, free glycine does promote the Cp hydrolysis
reaction, but the rate is slower than in the case of bisglycine derivative 13 in which the glycine
ligands are initially coordinated to the metal centre in the zwitterioninc form.
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Table 4: Hydrolysis of titanocene complexes dissolved in DMSO and left standing for various
lengths of time before adding D20 to give a 10% DMSO/D20 solution
Complex
Cp2TiCI2 1
CP2Ti(gly)2 13
Time in DMSO
(min) a
0.5
10
0.5
10
Reaction % Cp Hydrolysis
Time (h) b [15]
0.25 < 2
3 <2
24 <2
0.25 < 2
3 <2
24 <2
0.25 < 2
3 <2
24 <2
0.25 10
3 10
24 10
0.25 25
3 25
24 40
0.25 35
3 40
24 40
a 0 is the time taken when DMSO was added.; b 0 is the time taken when D20 was added.
In the case of complexes 8 and 13, rapid Cp hydrolysis occurred within 15 min (Figure
lb,lc), and after 24 h the singlets due to the metal bound Cp rings had completely disappeared
and only the characteristic cyclopentadiene (CpH) multiplets were observed. Solutions of 8 also
darkened after 24 h. As in the case of 1, a downfield DMSO multiplets appe.ared in these
experiments and were assigned tentatively to DMSO coordinated to titanium. This DMSO-Ti signal
increased in intensity with time and was the predominant species present after 24 h. A new
resonance also appeared in the spectra at around 8.4 ppm (Figure b, lc and d) and was
tentatively assigned as a binuclear degradation species similar to those reported previously, (eg.,
[Cp2Ti(X)O(X)TiCp2]2/ [18]). This resonance was sharp in solutions of complex 8 and broad in
solutions where glycine was present (Figure lc and ld).
In order to establish whether glycine, which appears to rapidly dissociate from the metal
when 13 is dissolved in DMSO, promotes the Cp hydrolysis reaction, glycine (HOOCCH2NH2, 2
mol equivalents) was added to a solution of Cp2TiCI2 1 and NMR spectra were recorded over 24 h.
After 15 min, approx 40% Cp hydrolysis had occurred, while after 3 h significant Cp hydrolysis
(80%) was observed (Figureld, Table 3). Thus, free glycine does promote the Cp hydrolysis
reaction, but the rate is slower than in the case of bisglycine derivative 13 in which the glycine
ligands are initially coordinated to the metal centre in the zwitterioninc form.
Hydrolysis in 10%DMSO/90%D20
Two different preparation methods were used (i) the sample was dissolved directly in
10%DMSO/D20 solution and (ii) the sample was dissolved in DMSO and then diluted with D20
(i.e., the method used for sample administration [19]) with accurate recording of the time the
sample was allowed to stand in DMSO before dilution with water.
(i) The rate of Cp hydrolysis of the complexes CP2TiX2 (X CI 1, OOCCCI2 8, glycine 13;
10 lmol) directly dissolved in 10%DMSO/90%D20 solutions is summarised in Table 3. The Cp
hydrolysis was estimated at <2% over 24 h for 1 and 8 as the amount of signal from CpH in the
NMR spectra was negligible. In the case of 13 the amount of bound Cp signal was reduced by
20% compared to the CH2 signal of glycine after 24 h and was attributed to Cp hydrolysis which
resulted in precipitation of a Cp containing species. For all complexes, the amount of precipitate
was negligible within 3 h and 20% for 13 after 24 h. The results confirm that 10%DMSO/90%D20
does not have a significant effect on Cp hydrolysis over several hours when this preparation
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method is employed, and the results are very similar to those obtained in water.
(ii) Table 4 summarises the results obtained for the complexes Cp2TiX2 (X CI 1,
OOCCCI3 8, glycine 13; 10 mol) when they were initially dissolved in 50 1 DMSO and left to stand
for 0.5, 3 and 10 min before addition of 450 1 of D20. In the case of titanocene dichloride 1
minimal precipitate was detected with time and there was no evidence of free Cp in solution or the
presence of any dicyclopentadiene (spectra not shown).
In the case of titanocene bis(glycine) 13 precipitation was observed to increase with time.
The % Cp hydrolysis was estimated by comparing the integral areas for the bound Cp resonance to
that for the CH2 resonance of the glycine ligand (spectra not shown). The results show that the %
Cp hydrolysis increased when the length of time that titanocene bis(glycine) 13 was allowed to
stand in DMSO was increased (Table 4). Further Cp hydrolysis was almost completely inhibited
upon dilution with D20.
Hydrolysis with titanocene bis(trichloroacetate) 8 was evident from both the formation of
precipitate with time and darkening of solutions. The initial concentration of complex dissolved in
DMSO was also important; lowering the concentration of the complex (10 mol to 6 mol) followed
by dilution with D20 showed only a very weak Cp signal in the NMR spectrum, and Cp hydrolysis
was estimated at > 90 % with the lower concentration of complex
DISCUSSION
While the antitumour activity of titanocene dichloride 1 has been recognised since 1980,
and the drug has been extensively tested against a wide range of tumours [1-3], the chemical basis
for the mechanism of antitumour action is poorly understood. Due to the limited aqueous solubility
of Cp2TiCI2 1, and the formation of precipitates at high pH, titanocene dichloride 1 has been
administered in 10%DMSO/90%saline solutions at low pH. The complex is typically dissolved in
DMSO and then diluted to the required volume [19]. In order to overcome potential problems
associated with precipitation upon intravenous administration and increase the bioavailability of the
drug, a number of active derivatives with improved aqueous solubility have been reported [11,12].
In the case of complexes 7, 8 and 9, the introduction of hydrophilic ligands resulted in (i) diminution
of toxic properties (ii) widening of the therapeutic range and (iii) an increase in aqueous solubility
for 7 and 9 which allowed the complexes to be administered in pure saline [11]. Moreover, a
further reduction in toxic properties was attained by elevation of the pH of the injected solution of
complex 7 in a manner similar to titanocene dichloride 1 [19]. However, in contrast to other
carboxylated complexes, the trichloroacetate derivative 8 did not exhibit improved aqueous
solubility, and hence administration was only carried out in 10%DMSO [11]. The bisglycine
derivate 13, while exhibiting excellent aqueous solubility, was tested in 10%DMSO, presumably to
allow comparison of the results with all previous studies [13].
Due to the use of DMSO in therapeutic mixtures, we have examined the relative stabilities
of metallocenes 1, 8 and 13 in three different solutions. Complex 1 was studied as the parent
metallocene undergoing clinical trials. The bisglycine analogue 13 was studied due to the
unexpected, reduced antitumour activity of this complex [13], and complex 8 was selected as a
representative of the hydrophilic carboxylate series [11] which has been screened against a
number of tumour types [20]. Comparison of the rate of Cp hydrolysis of these three metallocenes
in water, DMSO and 10%DMSO/90%D20 show several distinct trends. Firstly, the rate of Cp
hydrolysis of derivatives 8 and 13 is accelerated in DMSO compared with the parent compound 1.
Secondly, the hydrolysis reaction(s) in DMSO [15] to inactive titanocene species are highly
concentration dependent, as diluting the DMSO to ~10% with water effectively prevents further
degradation from occurring. Thus, for samples prepared in 10%DMSO, the amount of time
between when the sample is dissolved and then diluted with water is significant; after several
minutes as much as 40% of the species present in DMSO no longer contains the "Cp2Ti" moiety in
which the Cp rings remain coordinated to the titanium metal centre.
The rate of halide and Cp ring hydrolysis in titanocene dichloride 1 in water has been well-
characterised [6]. Rapid hydrolysis of the two halide ligands occurs in a series of equilibrium
reactions to give a solution of pH in which the Cp rings remain metal bound for > 24 h.
However, at higher pH values protonolysis of the Cp rings occurs to give cyclopentadiene and
dicyclopentadiene as well as insoluble, uncharacterised hydrolysis products. The exact nature of
the pseudohalide ligands have not been identified with Cp2TiCI2(aq) likely to contain a number of
species such as CP2Ti(H20)CI +, or CP2Ti(H20)x(OH)y(2Y).+ If we consider the effect of DMSO on
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this equilibrium, then our results (Figure 1, Table 3) show that the rate of Cp hydrolysis in DMSO is
slightly faster than in pure water at low pH. Direct evidence for formation of one or more species in
which DMSO coordinates to the metal centre is provided by the appearance of new DMSO
multiplets in the H NMR spectrum. However, more complete characterisation of these
degradation products was not possible.
In the case of 8 and 13, in the presence DMSO the rate of Cp hydrolysis is dramatically
increased compared to aqueous solutions of these complexes in water at low pH. While the exact
reasons for this and the mechanism by which the hydrolysis/displacement reactions occur are not
fully understood, there are a number of factors that may contribute to the results. Firstly, the lability
of the carboxylate-Ti bond in DMSO (and the liberated conjugate base of the carboxylic acid),
appear to be important in both 8 and 13 as the chloride ligands in titanocene dichloride 1 behave
differently. In the case of Cp2TiCI2 1, the chloride ligands dissociate and generate the coordinating
subunit "CP2Ti
2/’’ only when dissolved in water, while in DMSO, dissociation of the CI-Ti bond is
much slower. In contrast, in the case of 8 and 13, in DMSO both the carboxylate and Cp
hydrolysis reactions are fast. While DMSO contains a minor amount of water, the major role of the
DMSO solvent in the hydrolysis chemistry appears to be to displace the halide/carboxylate ligand
and activate the Cp ring to protonolysis.
As the major focus of our studies on antitumour metallocenes has been to attempt to
correlate the chemical stability and coordination chemistry of these complexes with their observed
antitumour properties, and thus provide the basis for rational drug design, we now compare the
hydrolysis results with the antitumour data in the literature. In the case of the glycine derivative 13,
our results suggest that administration of the complex in pure water should give improved results
compared to those in 10%DMSO. As the time between dissolving the complex in DMSO and
dilution with water is not given in the Experimental [13] (and is generally not important), it is
impossible to state unequivocally that Cp hydrolysis is responsible for very surprising reduced
activity results (Table 1). However, partial Cp hydrolysis in DMSO does offer a simple explanation
for the results and still supports the general hypothesis that the biologically active species
generated in vivo is "CP2Ti2+’’. A unique feature of the amino acid complexes 13 and 14, which
may play a role in the biological activity, is that they are zwitterionic and are present as the
hydrochloride salt in the complex. However, the thiophenol derivative 7 was also tested as the
hydrochloride salt and found to have maximum activity against EAT tumours (Table 1). It is
interesting that only sporadic cure rates, and the absence of strong dose-activity relationships was
observed for the corresponding orthoderivative 17 (Table 2) in which the amine is present in
neutral form, hinting that these sidechains may affect the subsequent chemistry.
The antitumour results obtained with the trichloroacetate derivative 8 are more difficult to
rationalise on a chemical basis (Table 1). This derivative retains the activity of the parent
derivative but the dose required to achieve an optimal cure rate is significantly increased compared
to other titanocene derivatives. Partial decomposition in DMSO could contribute to this dosage but
further comparative tests on a range of related titanocenes would be required to confirm this
hypothesis.
CONCLUSIONS
Our hydrolysis studies suggest that titanocene derivatives in which X CI, Br, retain
maximum antitumour activity. Certain carboxylate ligands such as in the complexes 8 and 13
promote hydrolysis/degradation reactions to biologically inactive species in DMSO in a process that
is DMSO concentration dependent. These results are consistent with the reduced activity
observed for the bisglycine analogue 13 and suggest that administration in the absence of DMSO
(as the complex is highly water soluble) or direct dissolution in 10%DMSO/90%saline may result in
modified cure rates. Direct dissolution of complex 8 in 10%DMSO/90%saline may also result in a
modified cure rate and optimum dose. The results emphasise the importance of examination of the
effect of coordinating solvents on the stability of metallocene complexes.
In terms of medicinal chemistry and the design and new transition metal drugs based on
the titanocene framework, our results support antitumour studies that indicate that a range of X
substituents may be incorporated into the Cp2TiX2 structure without loss of activity. However,
certain carboxylate based ligands appear to have reduced stability in DMSO solutions. Hence the
chemical hydrolysis reactions that occur in both water at low and elevated pH as well as the effect
of DMSO on new titanocene based anticancer drugs, needs to be taken into account in derivatives
that contain acid functional groups in the X ligands.
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